Financials Fortrea Holdings Inc.

Equities

FTRE

US34965K1079

Biotechnology & Medical Research

Market Closed - Nasdaq 04:00:00 2024-05-22 pm EDT 5-day change 1st Jan Change
26.38 USD +0.27% Intraday chart for Fortrea Holdings Inc. -8.31% -24.41%

Valuation

Fiscal Period: December 2023 2024 2025 2026
Capitalization 1 3,099 2,358 - -
Enterprise Value (EV) 1 4,583 3,934 3,764 3,567
P/E ratio -873 x -28.7 x 36.5 x 18.8 x
Yield - - - -
Capitalization / Revenue 1 x 0.82 x 0.78 x 0.74 x
EV / Revenue 1.47 x 1.36 x 1.25 x 1.13 x
EV / EBITDA 17.1 x 15.6 x 10.1 x 8.73 x
EV / FCF 36.1 x -296 x 23 x 16.9 x
FCF Yield 2.77% -0.34% 4.34% 5.9%
Price to Book 1.78 x 1.49 x 1.25 x 1.13 x
Nbr of stocks (in thousands) 88,800 89,374 - -
Reference price 2 34.90 26.38 26.38 26.38
Announcement Date 3/11/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2022 2023 2024 2025 2026
Net sales 1 - 3,109 2,890 3,024 3,169
EBITDA 1 - 267.3 252.8 372.3 408.4
EBIT 1 - 170.9 212.1 328.9 357.7
Operating Margin - 5.5% 7.34% 10.88% 11.29%
Earnings before Tax (EBT) 1 237 1.1 -131 37.85 113.9
Net income 1 192.9 -3.4 -57 59 114
Net margin - -0.11% -1.97% 1.95% 3.6%
EPS 2 - -0.0400 -0.9200 0.7233 1.400
Free Cash Flow 1 - 127.1 -13.31 163.5 210.4
FCF margin - 4.09% -0.46% 5.41% 6.64%
FCF Conversion (EBITDA) - 47.55% - 43.93% 51.53%
FCF Conversion (Net income) - - - 277.19% 184.59%
Dividend per Share 2 - - - - -
Announcement Date 5/15/23 3/11/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2023 Q2 2023 Q3 2023 Q4 2024 Q1 2024 Q2 2024 Q3 2024 Q4 2025 Q1
Net sales 1 793 776.4 775.4 662.1 718.6 741.2 760.8 753
EBITDA 1 72.5 70.5 67.2 29.5 51.92 76.17 93.76 71.35
EBIT 1 63 45.9 43.3 7.6 35.61 55.31 74.84 54.1
Operating Margin 7.94% 5.91% 5.58% 1.15% 4.95% 7.46% 9.84% 7.18%
Earnings before Tax (EBT) 1 - - -41 -77.5 -32.97 1.875 20.56 5.017
Net income 1 28.3 -13.1 -36 -102.8 - - - -
Net margin 3.57% -1.69% -4.64% -15.53% - - - -
EPS 2 0.3200 -0.1500 -0.4100 -1.150 -0.2300 0.0300 0.1650 0.0400
Dividend per Share 2 - - - - - - - -
Announcement Date 8/14/23 11/13/23 3/11/24 5/13/24 - - - -
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2022 2023 2024 2025 2026
Net Debt 1 - 1,483 1,576 1,407 1,209
Net Cash position 1 - - - - -
Leverage (Debt/EBITDA) - 5.55 x 6.235 x 3.778 x 2.96 x
Free Cash Flow 1 - 127 -13.3 164 210
ROE (net income / shareholders' equity) - 4.9% 3.94% 8.7% 8.66%
ROA (Net income/ Total Assets) - 2.88% 0.15% 3.11% 4.16%
Assets 1 - -118 -38,000 1,897 2,740
Book Value Per Share 2 - 19.60 17.70 21.10 23.40
Cash Flow per Share 2 - 1.970 0.8200 2.400 2.710
Capex 1 - 40.3 67.5 49.3 62.7
Capex / Sales - 1.3% 2.34% 1.63% 1.98%
Announcement Date 5/15/23 3/11/24 - - -
1USD in Million2USD
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Year-on-year evolution of the Yield

Change in Enterprise Value/EBITDA

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
8
Last Close Price
26.38 USD
Average target price
34.86 USD
Spread / Average Target
+32.13%
Consensus
  1. Stock Market
  2. Equities
  3. FTRE Stock
  4. Financials Fortrea Holdings Inc.